+44 (0) 20 7549 9987 | USA callers: +1 212 220 8419

Contact Us Now

“In-Vitro Fertilization (IVF) Market To Reach $45.0 Billion By 2029 says Visiongain report”, says Visiongain

08 January 2020
Pharma

Visiongain’s new report the In-Vitro Fertilization (IVF) Market Report: Forecasts by Instrument (Culture Media, Disposable Devices, Capital Equipment), by Treatment (Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen donor), by Application (Fertility Clinics, Hospitals, Others) plus analysis of leading companies operating in the global In-Vitro Fertilization market.

The global In-Vitro Fertilization market size was valued at $17.1 billion in 2019 and is expected to generate market revenue of $45.0 billion by the end of 2029 with a compound annual growth rate of 10.1%. Growing development of advanced technologies coupled with rising prevalence of infertility is expected to spur the market over the projected period. In-Vitro Fertilization is generally used to treat genetic problems or fertility. Supportive government regulations to encourage sperm freezing to stop chances of multiple pregnancies is projected to increase market concentration of In-Vitro Fertilization over the coming years. Additionally, technological advancement to enable pre identification of problems and diseases is expected to spur the market growth.

According to World Health Organization, One in every four couples in developing countries such as India, China, Brazil, Argentina, Peru, African countries, and Colombia had been found to be affected by infertility. Additionally, according to the American Society for Reproductive Medicine (ASRM), in 2018, infertility accounted for more than 7 million women in North America. Moreover, average age of marriage in developing as well as developed countries has increased over the past few years by virtue of increasing working population and increasing focus towards careers and the trends is expected to continue over the coming years.

Asia Pacific dominated overall In-Vitro Fertilization industry in 2018. Growing population, developing healthcare infrastructure in Malaysia, Indonesia, Singapore, and India is expected to prompted manufacturers to adopt plant expansion strategy. Moreover, availability of advanced technology in India, China, and Japan and low cost of treatment as compared to U.S. and European countries is expected to increase market reach over the coming years.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

12 April 2024

Read

Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034

The global Inflammatory Bowel Diseases (IBD) Drugs market was valued at US$27.53 billion in 2023 and is projected to grow at a CAGR of 6.2% during the forecast period 2024-2034.

11 April 2024

Read

Visiongain Publishes Female Health Tech Market Report 2024-2034

The global Female Health Tech market was estimated to be valued at US$ 140.9 billion in 2034 and is expected to register a CAGR of 9.6% from 2024 to 2034.

05 April 2024

Read

Visiongain Publishes Meningococcal Vaccines Market Report 2024-2034

The global Meningococcal Vaccines market is projected to grow at a CAGR of 2.5% by 2034

26 March 2024

Read